South Korea · Delayed Price · Currency is KRW Curexo Statistics
Total Valuation
Curexo has a market cap or net worth of KRW 453.86 billion. The enterprise value is 432.80 billion.
| Market Cap | 453.86B |
| Enterprise Value | 432.80B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Curexo has 41.26 million shares outstanding. The number of shares has increased by 1.30% in one year.
| Current Share Class | 41.26M |
| Shares Outstanding | 41.26M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 6.51% |
| Float | 28.54M |
Valuation Ratios
The trailing PE ratio is 214.75.
| PE Ratio | 214.75 |
| Forward PE | n/a |
| PS Ratio | 6.40 |
| PB Ratio | 4.62 |
| P/TBV Ratio | 4.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 202.55 |
| EV / Sales | 6.10 |
| EV / EBITDA | 128.29 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.73 |
| Quick Ratio | 9.43 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | -0.14 |
| Interest Coverage | 7.77 |
Financial Efficiency
Return on equity (ROE) is 2.22% and return on invested capital (ROIC) is 0.77%.
| Return on Equity (ROE) | 2.22% |
| Return on Assets (ROA) | 0.36% |
| Return on Invested Capital (ROIC) | 0.77% |
| Return on Capital Employed (ROCE) | 0.61% |
| Weighted Average Cost of Capital (WACC) | 9.78% |
| Revenue Per Employee | 675.41M |
| Profits Per Employee | 20.35M |
| Employee Count | 105 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Curexo has paid 31.31 million in taxes.
| Income Tax | 31.31M |
| Effective Tax Rate | 1.44% |
Stock Price Statistics
The stock price has increased by +13.17% in the last 52 weeks. The beta is 1.01, so Curexo's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +13.17% |
| 50-Day Moving Average | 14,088.20 |
| 200-Day Moving Average | 13,072.85 |
| Relative Strength Index (RSI) | 37.35 |
| Average Volume (20 Days) | 485,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Curexo had revenue of KRW 70.92 billion and earned 2.14 billion in profits. Earnings per share was 51.22.
| Revenue | 70.92B |
| Gross Profit | 23.00B |
| Operating Income | 606.24M |
| Pretax Income | 2.17B |
| Net Income | 2.14B |
| EBITDA | 3.37B |
| EBIT | 606.24M |
| Earnings Per Share (EPS) | 51.22 |
Balance Sheet
The company has 22.05 billion in cash and 990.83 million in debt, with a net cash position of 21.05 billion or 510.30 per share.
| Cash & Cash Equivalents | 22.05B |
| Total Debt | 990.83M |
| Net Cash | 21.05B |
| Net Cash Per Share | 510.30 |
| Equity (Book Value) | 98.28B |
| Book Value Per Share | 2,360.25 |
| Working Capital | 84.05B |
Cash Flow
In the last 12 months, operating cash flow was -4.82 billion and capital expenditures -2.37 billion, giving a free cash flow of -7.19 billion.
| Operating Cash Flow | -4.82B |
| Capital Expenditures | -2.37B |
| Depreciation & Amortization | 2.77B |
| Net Borrowing | -694.27M |
| Free Cash Flow | -7.19B |
| FCF Per Share | -174.21 |
Margins
Gross margin is 32.43%, with operating and profit margins of 0.85% and 3.01%.
| Gross Margin | 32.43% |
| Operating Margin | 0.85% |
| Pretax Margin | 3.06% |
| Profit Margin | 3.01% |
| EBITDA Margin | 4.76% |
| EBIT Margin | 0.85% |
| FCF Margin | n/a |
Dividends & Yields
Curexo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | 0.47% |
| FCF Yield | -1.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 5, 2006. It was a forward split with a ratio of 2.
| Last Split Date | Apr 5, 2006 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Curexo has an Altman Z-Score of 46.48 and a Piotroski F-Score of 4.
| Altman Z-Score | 46.48 |
| Piotroski F-Score | 4 |